With larger pipelines, and a complex clinical trial landscape, it’s difficult for manufacturers to build a single development plan, let alone try to optimize it. Benchmark data has historically been limited and manufacturers rely heavily on their own prior experiences. But the growth of “big data” and machine learning has provided new ways to optimize clinical development strategy.
In this webinar, we’ll discuss how “big” clinical and commercial data feeds, as well as powerful machine learning algorithms have fundamentally changed clinical development planning. We’ll discuss case studies showing the impact these new approaches have had in the industry. And we’ll show how a new breed of software tools can help internal stakeholders make better decisions more quickly.
For questions please contact Kristen Moore at email@example.com
© 2020. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union, and various other countries.